BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7828157)

  • 21. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
    Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic findings in primary and secondary MDS.
    Heim S
    Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
    Cermák J; Michalová K; Brezinová J; Zemanová Z
    Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
    Jotterand M; Parlier V
    Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
    Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
    Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
    Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelodysplastic syndrome: a study of prognostic factors.
    Lin JS; Lin CK; Liu SM; Chen LY; Wang SY
    J Formos Med Assoc; 1991 Mar; 90(3):232-9. PubMed ID: 1677397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-evaluation of refractory anemia with excess blasts in transformation.
    Ohyashiki K; Nishimaki J; Shoji N; Miyazawa K; Kimura Y; Ohyashiki JH
    Leuk Res; 2001 Nov; 25(11):933-9. PubMed ID: 11597728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 11 abnormalities in myelodysplastic syndromes.
    Collado R; Badía L; García S; Sánchez H; Prieto F; Carbonell F
    Cancer Genet Cytogenet; 1999 Oct; 114(1):58-61. PubMed ID: 10526536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?
    Wattel E; Laï JL; Hebbar M; Preudhomme C; Grahek D; Morel P; Bauters F; Fenaux P
    Leuk Res; 1993 Nov; 17(11):921-6. PubMed ID: 8231232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hematological study in 27 patients with myelodysplastic syndrome (MDS)].
    Arai T; Taoka T; Yamaoka G; Kiuchi H; Kawanishi K
    Rinsho Byori; 1993 Jan; 41(1):107-11. PubMed ID: 8355404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary myelodysplastic syndrome: an analysis of 56 patients.
    Chen PH; Kuo CY; Huang CH; Shih LY
    Changgeng Yi Xue Za Zhi; 1992 Sep; 15(3):121-7. PubMed ID: 1468034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
    Feng BZ; Lei JL; Han JZ
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
    Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ
    Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
    Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
    Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
    Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.